Written question asked by Harry Cohen (Labour), in the House of Commons. It was due for an answer on Wednesday, 14 June 1989. It was answered by David Mellor (Conservative) on Wednesday, 14 June 1989 on behalf of the Department of Health.
Untitled Written question
- Question
- What is policy on use of patients in UK for experimental test purposes for an American drug company provided that company holds valid clinical test certificate or clinical trial exemption certificate issued by UK licensing authority & what arrangments there are for patients to be informed that they are to be used for experimental test purposes
Secondary information
- Type
- Written question
- Reference
- 154 c425W;154 c423W
- Session
- 1988-89
- Subjects
- Disclosure of information Licensing Drugs Patients Testing USA Clinical trials
Librarians' tools
- Timestamp
- 2017-08-10 17:01:44 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_65892
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_65892
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_65892